Gabelli Funds’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Gabelli Funds’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-204,651	Closed	-$1.29M	–	1226
2022 Q4	$1.29M	Buy	204,651 +12,278	+6%	+$68K	0.01%	753
2022 Q3	$985K	Buy	192,373 +23,545	+14%	+$148K	0.01%	829
2022 Q2	$1.06M	Buy	+168,828	New	+$569K	0.01%	834

Gabelli Funds's FSTX Position: Q1 2023 in Review

Gabelli Funds sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 204,651 shares — an estimated $1.29M sold.

Gabelli Funds first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $1.29M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Gabelli Funds reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Gabelli Funds sold 204,651 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.29M.
Gabelli Funds first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Gabelli Funds's F-star Therapeutics, Inc. Common Stock position peaked at $1.29M in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.